Ardent Health, Inc.
NYSEArdent Health enters the back half of its earnings week with fresh momentum — a Q1 beat and held guidance have pushed the stock to its best level in months, yet the Street's cumulative target cuts tell a more complicated story underneath. The headline numbers are unambiguously positive. Q1 EPS came in at $0.28, well ahead of the $0.20 consensus estimate. Revenue hit $1.601 billion…
Snapshot as of 9 May 2026
Ardent Health enters the back half of its earnings week with fresh momentum — a Q1 beat and held guidance have pushed the stock to its best level in months, yet the Street's cumulative target cuts tell a more…
Ardent Health heads into its May 6 earnings call with the headline numbers already on the table — a Q1 beat that punched through modest expectations. The company posted Q1 EPS of $0.28, well clear of the $0.20…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARDT — free to start on ORTEX.
Sign up for free →Open ARDT on ORTEX